Sienna Cancer Diagnostics Ltd. announced the appointment of Immuno Diagnostic Oy as an exclusive distributor in Finland. The distribution agreement provides Immuno Diagnostic with the right to sell hTERT to Finnish pathology laboratories where it will be used to assist pathologists to diagnose bladder cancer. Approximately 1,200 new cases of bladder cancer are diagnosed in Finland each year. This is Sienna's fourth distributor appointment for Europe. The Company's hTERT product is CE-marked, whichconfirms that Sienna's product sold in the EU Market has demonstrated compliance with the In Vitro Diagnostic Medical Device Directive. Sienna will provide sales, marketing and technical support training to Immuno Diagnostic staff and establish a reference laboratory to assist in the adoption of hTERT in Finland.